We are live on ! Find out more
ARTL icon

Artelo Biosciences
ARTL

16 hedge funds and large institutions have $3.29M invested in Artelo Biosciences in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

52% more capital invested

Capital invested by funds: $2.17M → $3.29M (+$1.12M)

23% more funds holding

Funds holding: 13 → 16 (+3)

0.01% more ownership

Funds ownership: 0.03% → 0.04% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$777K
2
Renaissance Technologies
Renaissance Technologies
New York
+$705K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$329K
4
Two Sigma Investments
Two Sigma Investments
New York
+$207K
5
HighTower Advisors
HighTower Advisors
Illinois
+$78.6K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$166K
2
Citadel Advisors
Citadel Advisors
Florida
-$135K
3
Jane Street
Jane Street
New York
-$34K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$19.8K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$684
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.03M +$777K +2,274 +247%
Renaissance Technologies
2
Renaissance Technologies
New York
$663K +$705K +2,062 New
Two Sigma Advisers
3
Two Sigma Advisers
New York
$309K +$329K +963 New
BFM
4
Boothbay Fund Management
New York
$288K +$11.3K +33 +4%
KC
5
Kepos Capital
New York
$238K – – –
Two Sigma Investments
6
Two Sigma Investments
New York
$195K +$207K +607 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$167K -$684 -2 -0.4%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$103K -$19.8K -58 -15%
Citadel Advisors
9
Citadel Advisors
Florida
$88K -$135K -395 -59%
HighTower Advisors
10
HighTower Advisors
Illinois
$74K +$78.6K +230 New
UBS Group
11
UBS Group
Switzerland
$43K +$26.3K +77 +133%
VF
12
Virtu Financial
New York
$27K -$166K -486 -85%
PCM
13
Penserra Capital Management
California
$27K +$35.9K +105 New
LCM
14
LVM Capital Management
Michigan
$24K – – –
Northern Trust
15
Northern Trust
Illinois
$15K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$4K +$2.39K +7 +140%
Jane Street
17
Jane Street
New York
– -$34K -78 Closed
Bank of America
18
Bank of America
North Carolina
– -$342 -1 Closed

ARTL Hedge Fund Activity: Q2 2021 in Review

16 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2021, worth a combined $3.29M — up 52% from $2.17M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ARTL positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $777K. The largest seller was Virtu Financial, cutting an estimated $166K.

  • 16 institutional investors held Artelo Biosciences (ARTL) as of Q2 2021, up from 13 in Q1 2021.
  • Funds reported $3.29M of Artelo Biosciences stock for Q2 2021, up 52% quarter-over-quarter.
  • 5 funds opened new Artelo Biosciences positions in Q2 2021 and 2 closed out, a net change of +3 holders.
  • The largest Artelo Biosciences buyer in Q2 2021 was Vanguard Group, an estimated $777K added.
  • The largest Artelo Biosciences seller in Q2 2021 was Virtu Financial, an estimated $166K sold.

Based on aggregated 13F filings for Q2 2021.